The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results